Literature DB >> 21952942

NLRP3 inflammasome-mediated neutrophil recruitment and hypernociception depend on leukotriene B(4) in a murine model of gout.

Flávio A Amaral1, Vivian V Costa, Livia D Tavares, Daniela Sachs, Fernanda M Coelho, Caio T Fagundes, Frederico M Soriani, Tatiana N Silveira, Larissa D Cunha, Dario S Zamboni, Valerie Quesniaux, Raphael S Peres, Thiago M Cunha, Fernando Q Cunha, Bernhard Ryffel, Daniele G Souza, Mauro M Teixeira.   

Abstract

OBJECTIVE: Deposition of monosodium urate monohydrate (MSU) crystals in the joints promotes an intense inflammatory response and joint dysfunction. This study evaluated the role of the NLRP3 inflammasome and 5-lipoxygenase (5-LOX)-derived leukotriene B(4) (LTB(4) ) in driving tissue inflammation and hypernociception in a murine model of gout.
METHODS: Gout was induced by injecting MSU crystals into the joints of mice. Wild-type mice and mice deficient in NLRP3, ASC, caspase 1, interleukin-1β (IL-1β), IL-1 receptor type I (IL-1RI), IL-18R, myeloid differentiation factor 88 (MyD88), or 5-LOX were used. Evaluations were performed to assess neutrophil influx, LTB(4) activity, cytokine (IL-1β, CXCL1) production (by enzyme-linked immunosorbent assay), synovial microvasculature cell adhesion (by intravital microscopy), and hypernociception. Cleaved caspase 1 and production of reactive oxygen species (ROS) were analyzed in macrophages by Western blotting and fluorometric assay, respectively.
RESULTS: Injection of MSU crystals into the knee joints of mice induced neutrophil influx and neutrophil-dependent hypernociception. MSU crystal-induced neutrophil influx was CXCR2-dependent and relied on the induction of CXCL1 in an NLRP3/ASC/caspase 1/IL-1β/MyD88-dependent manner. LTB(4) was produced rapidly after injection of MSU crystals, and this was necessary for caspase 1-dependent IL-1β production and consequent release of CXCR2-acting chemokines in vivo. In vitro, macrophages produced LTB(4) after MSU crystal injection, and LTB(4) was relevant in the MSU crystal-induced maturation of IL-1β. Mechanistically, LTB(4) drove MSU crystal-induced production of ROS and ROS-dependent activation of the NLRP3 inflammasome.
CONCLUSION: These results reveal the role of the NLRP3 inflammasome in mediating MSU crystal-induced inflammation and dysfunction of the joints, and highlight a previously unrecognized role of LTB(4) in driving NLRP3 inflammasome activation in response to MSU crystals, both in vitro and in vivo.
Copyright © 2012 by the American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21952942     DOI: 10.1002/art.33355

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  91 in total

1.  Crystal arthritis: NLRP3 inflammasome mediates crystal-induced joint inflammation and dysfunction.

Authors:  Katrina Ray
Journal:  Nat Rev Rheumatol       Date:  2011-10-25       Impact factor: 20.543

2.  In vivo imaging of inflammasome activation reveals a subcapsular macrophage burst response that mobilizes innate and adaptive immunity.

Authors:  Pervinder Sagoo; Zacarias Garcia; Beatrice Breart; Fabrice Lemaître; David Michonneau; Matthew L Albert; Yves Levy; Philippe Bousso
Journal:  Nat Med       Date:  2015-12-21       Impact factor: 53.440

3.  The Long Pentraxin 3 Contributes to Joint Inflammation in Gout by Facilitating the Phagocytosis of Monosodium Urate Crystals.

Authors:  Nathália V Batista; Marialuisa Barbagallo; Vivian L S Oliveira; Thiago Castro-Gomes; Rene D R Oliveira; Paulo Louzada-Junior; Geraldo R C Pinheiro; Alberto Mantovani; Mauro M Teixeira; Cecilia Garlanda; Flávio A Amaral
Journal:  J Immunol       Date:  2019-02-04       Impact factor: 5.422

Review 4.  An old disease with new insights: Update on diagnosis and treatment of gout.

Authors:  Berivan Bitik; M Akif Öztürk
Journal:  Eur J Rheumatol       Date:  2014-06-01

5.  Interleukin-1 inhibition facilitates recovery from liver injury and promotes regeneration of hepatocytes in alcoholic hepatitis in mice.

Authors:  Arvin Iracheta-Vellve; Jan Petrasek; Benedek Gyogyosi; Shashi Bala; Timea Csak; Karen Kodys; Gyongyi Szabo
Journal:  Liver Int       Date:  2017-04-27       Impact factor: 5.828

6.  Study on the expressions of NLRP3 gene transcript variants in peripheral blood monocytes of primary gout patients.

Authors:  Wantai Dang; Dan Xu; Wenguang Xie; Jingguo Zhou
Journal:  Clin Rheumatol       Date:  2018-06-26       Impact factor: 2.980

7.  Leukotriene B4 licenses inflammasome activation to enhance skin host defense.

Authors:  Ana Carolina Guerta Salina; Stephanie L Brandt; Nathan Klopfenstein; Amondrea Blackman; Júlia Miranda Ribeiro Bazzano; Anderson Sá-Nunes; Nicole Byers-Glosson; Claudia Brodskyn; Natalia Machado Tavares; Icaro Bonyek Santos Da Silva; Alexandra I Medeiros; C Henrique Serezani
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-12       Impact factor: 11.205

8.  The role of annexin A1 in the modulation of the NLRP3 inflammasome.

Authors:  Izabela Galvão; Renan V H de Carvalho; Juliana P Vago; Alexandre L N Silva; Toniana G Carvalho; Maísa M Antunes; Fabiola M Ribeiro; Gustavo B Menezes; Dario S Zamboni; Lirlândia P Sousa; Mauro M Teixeira
Journal:  Immunology       Date:  2020-03-30       Impact factor: 7.397

9.  IL-33 enhances macrophage release of IL-1β and promotes pain and inflammation in gouty arthritis.

Authors:  Victor Fattori; Larissa Staurengo-Ferrari; Tiago H Zaninelli; Rubia Casagrande; Rene D Oliveira; Paulo Louzada-Junior; Thiago M Cunha; Jose C Alves-Filho; Mauro M Teixeira; Fernando Q Cunha; Flavio A Amaral; Waldiceu A Verri
Journal:  Inflamm Res       Date:  2020-09-04       Impact factor: 4.575

10.  Risk of incident atrial fibrillation in gout: a cohort study.

Authors:  Seoyoung C Kim; Jun Liu; Daniel H Solomon
Journal:  Ann Rheum Dis       Date:  2015-08-31       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.